Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Home
ETF
SLS
SLS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SLS News
Sellas Immunotherapy Advances with Galinpepimut-S
1d ago
stocktwits
Sellas' Immunotherapy Trial Approaches Key Milestone
11h ago
stocktwits
Wall Street Rebounds Amid Oil Price Volatility
13h ago
stocktwits
Sellas Life Sciences Stock Volatility Amid AML Summit Insights
4d ago
stocktwits
Sellas Life Sciences Stock Soars Ahead of Key AML Trial Data
5d ago
stocktwits
SELLAS Life Sciences Stock Surges Over 200% Amid Positive Trial Data
5d ago
Benzinga
Sellas Life Sciences Stock Soars Ahead of Key AML Trial Data
6d ago
stocktwits
SELLAS GPS Trial Progress Captivates Investors
Feb 27 2026
stocktwits
Sellas CEO Highlights Progress in Phase 3 REGAL Trial
Feb 23 2026
stocktwits
SELLAS Life Sciences Expands SLS009 Clinical Study with IMPACT-AML in Europe
Jan 14 2026
stocktwits
SELLAS Life Sciences Partners with IMPACT-AML to Advance SLS009 Clinical Trials
Jan 14 2026
Newsfilter
Oncolytics Biotech Fortifies IP Protection, Extends Pelareorep Commercial Runway to 2044
Jan 08 2026
Globenewswire
Intelligent Bio Solutions Plans $10 Million Private Placement, Shares Plunge 19.7%
Jan 02 2026
Benzinga
Ironwood Pharmaceuticals Issues FY26 Guidance, Shares Surge 57.7%
Jan 02 2026
Benzinga
ARS Pharma's Neffy Approved in China for Allergy Treatment
Jan 02 2026
NASDAQ.COM
Baidu Inc Proposes Spinoff of Kunlunxin H Shares, Stock Rises 12.3%
Jan 02 2026
Benzinga
Show More News
